DE69230037D1 - Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien - Google Patents

Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien

Info

Publication number
DE69230037D1
DE69230037D1 DE69230037T DE69230037T DE69230037D1 DE 69230037 D1 DE69230037 D1 DE 69230037D1 DE 69230037 T DE69230037 T DE 69230037T DE 69230037 T DE69230037 T DE 69230037T DE 69230037 D1 DE69230037 D1 DE 69230037D1
Authority
DE
Germany
Prior art keywords
cell line
cockidia
continuous cell
pct
vaccine against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230037T
Other languages
English (en)
Other versions
DE69230037T2 (de
Inventor
Robert Clare
Patricia Lufburrow
Timothy Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69230037D1 publication Critical patent/DE69230037D1/de
Publication of DE69230037T2 publication Critical patent/DE69230037T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
DE69230037T 1991-07-12 1992-07-10 Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien Expired - Fee Related DE69230037T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72925691A 1991-07-12 1991-07-12
PCT/US1992/005797 WO1993001276A1 (en) 1991-07-12 1992-07-10 Continuous cell line and vaccine against avian coccidia

Publications (2)

Publication Number Publication Date
DE69230037D1 true DE69230037D1 (de) 1999-10-28
DE69230037T2 DE69230037T2 (de) 2000-01-05

Family

ID=24930240

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230037T Expired - Fee Related DE69230037T2 (de) 1991-07-12 1992-07-10 Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien

Country Status (10)

Country Link
US (2) US5674484A (de)
EP (1) EP0594743B1 (de)
JP (1) JP3129441B2 (de)
AT (1) ATE184912T1 (de)
CA (1) CA2112811C (de)
DE (1) DE69230037T2 (de)
DK (1) DK0594743T3 (de)
ES (1) ES2137190T3 (de)
GR (1) GR3032204T3 (de)
WO (1) WO1993001276A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3120860B2 (ja) 1995-06-07 2000-12-25 ファイザー・インコーポレーテッド コクシジウム症に対する卵内予防接種
SK282436B6 (sk) 1995-06-07 2002-02-05 Pfizer Inc. Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky
CA2213385A1 (en) 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
US6605460B1 (en) 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine
CN103316371A (zh) 2001-08-30 2013-09-25 恩布里克斯公司 制备卵囊的改进方法
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
WO2003099325A1 (en) 2002-05-21 2003-12-04 Schering-Plough Ltd. Methods for the in vitro culture of sporozoea sp. and user thereof
EP1565478B1 (de) 2002-11-12 2017-08-02 The Brigham And Women's Hospital, Inc. Polysaccharidimpfstoff gegenstaphylokokkeninfektionen
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
AU2003297719A1 (en) * 2002-12-09 2004-06-30 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine
DE602005021873D1 (de) 2004-03-12 2010-07-29 Univ Georgia Neues impfstoffadjuvans und dessen herstellung und verwendung
PL1745075T3 (pl) 2004-04-21 2013-09-30 Brigham & Womens Hospital Inc Peptydy wiążące poli-N-acetyloglukozaminę (PNAG/DPNAG) i sposoby ich zastosowania
US7897150B1 (en) * 2007-04-09 2011-03-01 The Ohio State University Canine lymphoma cell line and uses thereof
EP2315747B1 (de) 2008-07-21 2017-12-06 The Brigham and Women's Hospital, Inc. Verfahren und zusammensetzungen in verbindung mit synthetischen beta-1,6 glucosamin-oligosacchariden
JP5642710B2 (ja) * 2009-01-22 2014-12-17 ユニバーシティ オブ ジョージア リサーチ ファンデーション，インコーポレーテッド マイコプラズマ・ガリセプティカム製剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
US4650676A (en) * 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
US4710377A (en) * 1983-08-19 1987-12-01 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4874705A (en) * 1985-05-16 1989-10-17 Solvay & Cie, S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
ES2031819T3 (es) * 1985-12-03 1993-01-01 Solvay Un metodo de preparar una proteina antigenica derivada de eimeriatenella.
US5028694A (en) * 1985-12-03 1991-07-02 Solvay & Cie, S.A. Antigenic proteins and vaccines containing them for prevention of coccidiosis caused by eimeria Eimeria necatrix and Eimeria tenella
US4753798A (en) * 1986-06-30 1988-06-28 American Cyanamid Company Methods and compositions for controlling protozoal infections in warm-blooded animals
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
NZ232372A (en) * 1989-02-10 1993-04-28 Merck & Co Inc Glycolipid-linked membrane-associated immunogens of eimeria useful in immunising poultry against coccidiosis
AU654481B2 (en) * 1991-03-14 1994-11-10 British Technology Group Usa, Inc. Recombinant anticoccidial vaccine
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines

Also Published As

Publication number Publication date
EP0594743B1 (de) 1999-09-22
JP3129441B2 (ja) 2001-01-29
DE69230037T2 (de) 2000-01-05
GR3032204T3 (en) 2000-04-27
EP0594743A1 (de) 1994-05-04
CA2112811C (en) 2004-01-13
ATE184912T1 (de) 1999-10-15
WO1993001276A1 (en) 1993-01-21
JPH07505041A (ja) 1995-06-08
DK0594743T3 (da) 1999-12-20
ES2137190T3 (es) 1999-12-16
EP0594743A4 (de) 1995-01-25
US5846527A (en) 1998-12-08
CA2112811A1 (en) 1993-01-21
US5674484A (en) 1997-10-07

Similar Documents

Publication Publication Date Title
DE69230037D1 (de) Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE59508891D1 (de) Hautpflegemittel
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
BR9508655A (pt) Composição farmacêutica aquosa estéril
TR25681A (tr) Agiz ici temizlik ve bakimini saglamaya yönelik bilesimler.
DK0850068T3 (da) Lipidekstrakt med antiinflammatorisk aktivitet
NO2012003I2 (no) 4-aminopyridin
DE69110678T2 (de) Prophylaktische und therapeutische anwendungen von peroxidasen.
FI923357A0 (fi) Framstaellning av fettsyramediciner.
ATE134514T1 (de) Implantat mit durchgangsöffnung
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
DK0981347T3 (da) Anvendelsen af levobupivacain i ansigtkirurgi
TW261532B (de)
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
DK0663832T3 (da) Anvendelse af 4'-iod-4'-deoxydoxorubicin til behandling af amyloidose
SE9504267D0 (sv) New therapeutic use
SE9403861D0 (sv) Novel medicinal use
DE69634536D1 (de) 2,4-dichlorbenzylalkohol und amylmetakresol gegen hiv-infektion
ES2120251T3 (es) 3-alcoxicarbonil-tiadiazinonas cardioactivas.
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
ITRM910881A0 (it) Didpoditivo elettronico e computerizzato per l'espressione e la comunicazione di sordociechi e altri pluriminorati
NO307204B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter ved behandling av stråleskader

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee